全文获取类型
收费全文 | 1012篇 |
免费 | 144篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 64篇 |
妇产科学 | 25篇 |
基础医学 | 208篇 |
口腔科学 | 19篇 |
临床医学 | 114篇 |
内科学 | 122篇 |
皮肤病学 | 36篇 |
神经病学 | 77篇 |
特种医学 | 49篇 |
外科学 | 105篇 |
综合类 | 28篇 |
一般理论 | 2篇 |
预防医学 | 135篇 |
眼科学 | 29篇 |
药学 | 43篇 |
中国医学 | 1篇 |
肿瘤学 | 106篇 |
出版年
2021年 | 11篇 |
2020年 | 15篇 |
2019年 | 8篇 |
2018年 | 19篇 |
2017年 | 14篇 |
2016年 | 20篇 |
2015年 | 23篇 |
2014年 | 22篇 |
2013年 | 37篇 |
2012年 | 49篇 |
2011年 | 50篇 |
2010年 | 39篇 |
2009年 | 23篇 |
2008年 | 44篇 |
2007年 | 55篇 |
2006年 | 40篇 |
2005年 | 47篇 |
2004年 | 35篇 |
2003年 | 29篇 |
2002年 | 35篇 |
2001年 | 24篇 |
2000年 | 30篇 |
1999年 | 29篇 |
1998年 | 24篇 |
1997年 | 21篇 |
1996年 | 28篇 |
1995年 | 20篇 |
1994年 | 19篇 |
1993年 | 15篇 |
1992年 | 14篇 |
1990年 | 14篇 |
1989年 | 16篇 |
1988年 | 19篇 |
1987年 | 18篇 |
1986年 | 14篇 |
1985年 | 17篇 |
1984年 | 14篇 |
1982年 | 9篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 14篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1974年 | 8篇 |
1973年 | 10篇 |
1971年 | 10篇 |
1969年 | 9篇 |
1968年 | 11篇 |
1967年 | 10篇 |
1960年 | 9篇 |
排序方式: 共有1163条查询结果,搜索用时 15 毫秒
61.
The authors sought to determine the prevalence of marijuana use in patients with epilepsy by performing a telephone survey in a tertiary care epilepsy center. Twenty-one percent of subjects had used marijuana in the past year with the majority of active users reporting beneficial effects on seizures. Twenty-four percent of all subjects believed marijuana was an effective therapy for epilepsy. Despite limited evidence of efficacy, many patients with epilepsy believe marijuana is an effective therapy for epilepsy and are actively using it. 相似文献
62.
Ashworth M Lea R Gray H Rowlands G Gravelle H Majeed A 《Journal of public health (Oxford, England)》2004,26(1):48-51
METHODS: Primary care organizations (PCOs) in England are required to run a prescribing incentive scheme. The average payment received by general practitioners (GPs) under these schemes is not known. We conducted a longitudinal (2 year) questionnaire study of all PCOs in London and the south east of England aiming to explore the relationship between the financial incentives, the selection of prescribing indicators and success at remaining within budget. In the second year, the average reward per GP amounted to 1220 pounds (range 470 pounds-4330 pounds). Underspent PCOs made larger incentive scheme payments to their practices as did PCOs that had successfully overturned a first year overspend into a second year underspend. The size of rewards was unrelated to the selection of any particular cost- or quality-based prescribing indicator. We conclude that larger prescribing incentive scheme payments may have contributed to prescribing cost control but their effect on prescribing quality is uncertain. 相似文献
63.
Germline mutations in the BRCA1, BRCA2 and Fanconi anaemia genes confer cancer susceptibility, and the proteins encoded by these genes have distinct functions in related DNA-repair processes. Emerging evidence indicates that these processes are disrupted by numerous mechanisms in sporadic cancers. Collectively, there are properties that define 'BRCAness' - that is, traits that some sporadic cancers share with those occurring in either BRCA1- or BRCA2-mutation carriers. These common properties might have important implications for the clinical management of these cancers. 相似文献
64.
Warren M Smith A Partridge N Masabanda J Griffin D Ashworth A 《Human molecular genetics》2002,11(7):841-851
Carriers of mutations in the BRCA2 gene have a high risk of developing breast and other cancers. The BRCA2 gene, which is located on human chromosome 13, encodes a very large protein of only poorly understood function. To define regions of sequence conservation and highlight potentially functionally important domains, we have cloned and characterized the chicken BRCA2 gene, the first non-mammalian BRCA2 gene to be described. The gene is organized similarly to the human BRCA2 gene, but is more compact and is localized to the subtelomeric region of chicken chromosome 1q, within a region that contains other genes from human chromosome 13. The chicken BRCA2 gene encodes a protein of 3399 amino acids, which is poorly conserved with mammalian BRCA2 proteins, having only 37% amino acid identity overall with human BRCA2. However, certain domains are much more highly conserved, indicating functional significance. We describe genes with some of these conserved domains in organisms as diverse as intracellular parasites, mosquitoes and plants. The evolutionarily divergent chicken BRCA2 sequence may also be useful in assigning the large number of sequence variants that have been described in the human BRCA2 gene which are of unknown significance in disease causation. 相似文献
65.
66.
67.
68.
69.
Evidence from genetic linkage analysis indicates that a gene located at 19q13.4, FWT2, is responsible for predisposition to Wilms tumor in many Wilms tumor families. This region has also been implicated in the etiology of sporadic Wilms tumor through loss of heterozygosity analyses. The PPP2R1A gene, encoding the alpha isoform of the heterotrimeric serine/threonine protein phosphatase 2A (PP2A), is located within the FWT2 candidate region and is altered in breast and lung carcinomas. PPP2R1B, encoding the beta isoform, is mutated in lung, colon, and breast cancers. These findings suggested that both PPP2R1A and PPP2R1B may be tumor suppressor genes. Additionally, PP2A is important in fetal kidney growth and differentiation and has an expression pattern similar to that of the Wilms tumor suppressor gene WT1. Since PPP2R1A was therefore a compelling candidate for the FWT2 gene, we analysed the coding region of PPP2R1A in DNA and RNA samples from affected members of four Wilms tumor families and 30 sporadic tumors and identified no mutations in PPP2R1A in any of these 34 samples. We conclude that PPP2R1A is not the 19q familial Wilms tumor gene and that mutation of PPP2R1A is not a common event in the etiology of sporadic Wilms tumor. 相似文献
70.